Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comorbidity and adverse events in acquired hemophilia A: data from the GTH-AHA-EMI study.
Burgmann CH, Sachs UJ, Trautmann-Grill K, Pfrepper C, Knöbl P, Greil R, Oldenburg J, Miesbach W, Holstein K, Eichler H, Möhnle P, Höpting M, Dobbelstein C, Klamroth R, Tiede A. Burgmann CH, et al. Among authors: tiede a. Res Pract Thromb Haemost. 2024 Sep 5;8(7):102565. doi: 10.1016/j.rpth.2024.102565. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39420971 Free PMC article.
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Tiede A, Hart C, Knöbl P, Greil R, Oldenburg J, Sachs UJ, Miesbach W, Pfrepper C, Trautmann-Grill K, Holstein K, Pilch J, Möhnle P, Schindler C, Weigt C, Schipp D, May M, Dobbelstein C, Pelzer FJ, Werwitzke S, Klamroth R. Tiede A, et al. Lancet Haematol. 2023 Nov;10(11):e913-e921. doi: 10.1016/S2352-3026(23)00280-6. Epub 2023 Oct 16. Lancet Haematol. 2023. PMID: 37858328 Clinical Trial.
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
Hart C, Klamroth R, Sachs UJ, Greil R, Knoebl P, Oldenburg J, Miesbach W, Pfrepper C, Trautmann-Grill K, Pekrul I, Holstein K, Eichler H, Weigt C, Schipp D, Werwitzke S, Tiede A. Hart C, et al. Among authors: tiede a. J Thromb Haemost. 2024 Oct;22(10):2692-2701. doi: 10.1016/j.jtha.2024.06.010. Epub 2024 Jun 25. J Thromb Haemost. 2024. PMID: 38936699 Free article.
Real-world usage and effectiveness of recombinant factor VIII/factor IX Fc in hemophilia A/B: final data from the 24-month, prospective, noninterventional PREVENT study in Germany.
Bidlingmaier C, Heller C, Langer F, Miesbach W, Scholz U, Oldenburg J, Nüesch E, Palmborg H, Santagostino E, Tiede A. Bidlingmaier C, et al. Among authors: tiede a. Res Pract Thromb Haemost. 2024 Jun 21;8(5):102482. doi: 10.1016/j.rpth.2024.102482. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39101128 Free PMC article.
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.
Tiede A, Klamroth R, Scharf RE, Trappe RU, Holstein K, Huth-Kühne A, Gottstein S, Geisen U, Schenk J, Scholz U, Schilling K, Neumeister P, Miesbach W, Manner D, Greil R, von Auer C, Krause M, Leimkühler K, Kalus U, Blumtritt JM, Werwitzke S, Budde E, Koch A, Knöbl P. Tiede A, et al. Blood. 2015 Feb 12;125(7):1091-7. doi: 10.1182/blood-2014-07-587089. Epub 2014 Dec 18. Blood. 2015. PMID: 25525118 Free PMC article.
181 results